Navigation Links
Clarient, BioView Initiate Alliance to Finalize Development and Commercialize Non-Invasive Molecular Diagnostic Test for Early Detection of Lung Cancer
Date:12/14/2009

ion of lung cancer," Dr. Schwebel said. "We are excited to have Clarient, with its long history of collaborating with academia and innovative companies in developing novel oncology tests utilizing biomarkers, as our first partner to develop a test based on our proprietary probes and technologies. We are confident that our collaboration with Clarient will successfully help to develop, validate and commercialize the test through its established pathways to the market."

Clarient Chief Executive Officer Ron Andrews said the test could become a very valuable tool for detecting lung cancer and for expanding Clarient's lung cancer franchise. "This test has promise to become a valuable diagnostic and prognostic tool for determining the risk of lung cancer for many patients, but particularly for smokers," Andrews said. "Lung cancer continues to be an area of focus in the coming months for Clarient and we are particularly interested in working with pharmaceutical companies that are developing smoking cessation drugs. We look forward to our collaboration with BioView on these confirmatory studies and possible commercialization of this test."

Andrews estimated that the validation studies should be completed during 2010.

About BioView Ltd.

Established in 2000, and led by an expert team of biologists, software engineers and physicists, BioView develops, manufactures and supplies cell imaging equipment, biological kits and software to medical institutes and universities. BioView is a publicly traded company on the Israeli Stock exchange, and currently has strategic collaborations underway with international scientific leaders and institutions. For more information about the BioView technology, and press related issues, please contact alan@bioview.co.il or visit our website at www.bioview.
'/>"/>

SOURCE Clarient, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioView Reports Interim Results of Early Detection Lung Cancer Diagnostic Test
2. Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
3. Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimers Disease
4. Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients
5. New Research Shows Over-use of Asthma Rescue Inhalers Substantially Reduced Through Pharmacist-initiated Physician Intervention
6. Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients
7. Incept BioSystems Initiates First Human Clinical Trial of its SMART Embryo Culture System for In Vitro Fertilization (IVF)
8. Abbotts XIENCE V(R) Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS(R) Liberte in Investigator-Initiated COMPARE Trial
9. Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
10. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
11. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... NEW YORK , July 7, 2015 /PRNewswire/ ... of a new generation of drugs within human ... established a sales company in the ... for Paccal Vet-CA1, its leading companion animal therapeutic. ...      (Photo: http://photos.prnewswire.com/prnh/20150703/228329 ) , ...
(Date:7/7/2015)... , July 7, 2015   Mallinckrodt plc ... results on Tuesday, August 4, 2015. A conference call for ...   The call can be accessed in ... http://www.mallinckrodt.com/investors . , By telephone: For both listen-only participants ... portion of the call, the telephone dial-in number in the ...
(Date:7/7/2015)... 7, 2015 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug ... non-binding Letter of Intent (LoI) for an investment and ... Sinopharm Capital Management Co. Ltd. and Hefei Life Science ... Hefei ) potentially valued at $50,000,000 plus ...
Breaking Medicine Technology:Oasmia Pharmaceutical Launches US Brand and Sales Platform 2Mallinckrodt plc To Report Third Quarter Fiscal 2015 Results On August 4, 2015 2Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 2Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 3Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 4Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 5
... (NYSE: BSX ) is scheduled to present at ... Ray Elliott, President and Chief Executive Officer, will ... at approximately 9:30 a.m. PT.  Following the presentation, Jeff Capello, ... Elliott in a question and answer session. A ...
... Calif., Dec. 27, 2010 King Pharmaceuticals®, Inc. ... PTIE ) today announced that King has resubmitted ... U.S. Food and Drug Administration (FDA) in response to a ...  This is a Class 2 resubmission with a six month ...
Cached Medicine Technology:King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY® 2King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY® 3
(Date:7/7/2015)... ... July 07, 2015 , ... Isabel ... jointly announced a partnership focused on providing knowledge organizing and differential diagnostic support ... will be conducted with NIWH trained patient health educators, utilizing the Knowledge Organizer ...
(Date:7/7/2015)... , ... July 07, 2015 , ... ... announce the launch of their new website, the Invokana Ketoacidosis Lawsuit Center ... warning*, and serves as a resource for persons wishing to learn more about ...
(Date:7/7/2015)... ... 2015 , ... CareSync proudly announces today that Amy Gleason, ... House as a “Champion of Change” for Precision Medicine on Wednesday, July 8th. ... Change program recognizes Gleason and eight other extraordinary individuals who are making great ...
(Date:7/6/2015)... ... July 07, 2015 , ... Currently, mobile testing ... of AIDS, advances in the molecular diagnostic technologies, wide availability of immunosuppressive drugs ... detection technologies and genetic engineering also open lucrative opportunities for the market players. ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... “ TapGlance ... look at the latest and coolest applications on the market for iOS, Android, and ... and shared with viewers how this interior design app helps users visualize what rooms ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 2Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 3Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 3Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 2Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 3Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2
... suffered from depression before the diagnosis, , , FRIDAY, May ... than twice as likely to develop post-traumatic stress disorder ... new research suggests. , About 16 percent of the ... Ohio State University Medical experienced PTSD 18 months after ...
... Force,Colonel Mike Turner, a Democratic candidate for U.S. Congress ... inspired by MSNBC host,Keith Olbermann. Today is the 169th ... key architect of Hillary Clinton,s,notorious 1993 health care plan, ... 10th District voters what, if any, plan she has ...
... Calif., May 9 Dakim, Inc., announced,today that ... in,health and fitness, has signed on as a ... [m]Power Cognitive Fitness System, joining the,company,s efforts to ... is a touch screen-based brain workout program designed,to ...
... provide more visible presence for world,s largest surgical,organization, ... today broke ground for a new home for its ... on Capitol Hill. The,10-story, class A office building, located ... first quarter of 2010. ACS headquarters will remain in ...
... ,SELF MEDICATION, FOR DEPRESSION LEADS TO MORE SERIOUS MENTAL ILLNESS, ... ... to Relieve Symptoms, WASHINGTON, May 9 Millions of American teens ... many of these depressed teens are using marijuana and other,drugs, making their ...
... 2008 As controversy swirls about proper clinical use of ... American Pain Society annual meeting shows that, contrary to widespread ... of drug abuse who are prescribed opioids for chronic pain ... , In his plenary session address, Srinivasa ...
Cached Medicine News:Health News:Mood Disorders Put Breast Cancer Patients at Risk for PTSD 2Health News:Mike Turner, Virginia Congressional Candidate, Starts Healthcare Countdown 2Health News:Physical Fitness 'Godfather' Jack LaLanne Turns to Brain Fitness, Becoming Ambassador for Dakim's [m]Power System 2Health News:American College of Surgeons Breaks Ground on New Office Building on Capitol Hill 2Health News:White House Office of National Drug Control Policy National Youth Anti-Drug Media Campaign 2Health News:White House Office of National Drug Control Policy National Youth Anti-Drug Media Campaign 3Health News:Risks for painkiller abuse do not outweigh benefits in chronic pain 2
... Perfect Single Vac Manifold is ... plate in 30 minutes; the ... "open/closed" switch and a vacuum ... operation. contains vacuum chamber, on/off ...
... The TurboVap Concentration Workstations from Caliper provide an automated alternative to Kuderna-Danish, Rotary, Vacuum-Style and Nitrogen ... in use around the world today. ... ... ...
Plastic Tray Type Vacuum Manifold...
... Vacuum Manifold system for sample processing consists ... a vacuum is applied, a chemical-resistant polypropylene ... convenience in sample handling. The manifold is ... up to 12 samples simultaneously. Loading, washing, ...
Medicine Products: